Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) - Wikidata - wikimedia - TriplyDB

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)

http://www.wikidata.org/entity/Q28211911

about

sameAs

CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)Integrin alpha5beta1 and ADAM-17 interact in vitro and co-localize in migrating HeLa cells Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme Osteoarthritis joint pain: the cytokine connection Microglia centered pathogenesis in ALS: insights in cell interconnectivity Heterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary disease Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26 Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1 Greater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with males Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction Do not let death do us part: 'find-me' signals in communication between dying cells and the phagocytes.Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.Cytoskeletal confinement of CX3CL1 limits its susceptibility to proteolytic cleavage by ADAM10 The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.Circulating fractalkine levels predict the development of the metabolic syndrome.Tumor Therapy Applying Membrane-bound Form of Cytokines.SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.ADAM17 deletion in thymic epithelial cells alters aire expression without affecting T cell developmental progression ADAM-17: the enzyme that does it all.Interactions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons.Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles Cloning and expression of ADAM-related metalloproteases in equine laminitis Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies.Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx.Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα Fractalkine/CX3CL1: a potential new target for inflammatory diseases Fractalkine promotes human monocyte survival via a reduction in oxidative stress The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?

P2860

Q21129473-FA02EC89-8DBE-4508-9C9C-8FF6B73DD7B6 Q24300017-28F9F138-735D-486F-A839-48F82294A4A7 Q24300694-2F5534C0-6300-42F1-961A-A0EF06910360 Q24306455-EF3BA4BB-4F4F-40B6-8C44-006954B2F078 Q24309589-66BDB236-3151-4763-BFC9-7EE2A9CEAEF3 Q24317214-02AA48C1-1D99-4EE8-981B-AB28F717B395 Q24534110-7FEC4FEB-E9BC-4AA2-A414-9976C33E5D4B Q26859004-BDDBD3B6-22B7-42CD-9D67-5CF323BFB995 Q27009559-8C135A84-E084-4269-B7C9-F0EAF9D1B98D Q27014453-095F6EF3-B3EA-4F70-B6AD-3E3B64A7F7CF Q28072580-8B2ECC95-F8EA-4209-935D-15E32B12B577 Q28119172-16DE1276-671F-4A30-ADF9-7DE775536680 Q28571899-0A7C784B-8222-4286-9B19-D665EC1920DC Q28576101-A8BEAAE2-F272-4CF1-8147-008E776C9F3F Q28601403-528FC427-BE42-4318-86F5-008EB75890B2 Q28972215-91FA0B1B-FAC4-49DF-861D-857F0137BA28 Q30277318-42EC362A-5115-45C6-B91E-3E241A179C4A Q30360306-EC4D1DC0-5DC9-4A58-825D-3462C06B2BD9 Q30601949-9BEAB5B8-DD22-4309-8AD4-74782CA09138 Q31160040-71D34944-9353-4825-A419-ECD6B8F6B1A8 Q33580505-5B509684-D8B2-4972-A6B3-6659719F14F8 Q33614646-741036EC-80A0-4B5D-B08E-FF2445B1DC19 Q33631960-2F015585-DAAB-4923-BEE2-C6128E3D8410 Q33645235-806357CA-50A5-4946-A841-B20C198474B7 Q33728091-A0AA1FDC-DE8F-4078-8F3A-82664F72D301 Q33737421-7D053E76-2910-421A-B0D3-D7C3F636A17F Q33796131-9C27B09F-8D36-4445-B3C6-C31C1CCB4937 Q33959320-BFCA95A6-C118-4807-9445-E84EC71DF584 Q34002086-5E4B6BAE-8B76-4D5A-B409-36B0FE61FF38 Q34009507-9C5FC31E-B452-4A1F-9596-356A4D04D66B Q34033832-D7D733F9-9A7A-415A-A397-A7CC7A038741 Q34142149-15DFA135-15AE-4300-B035-70AE534EDC4D Q34162803-4B989594-9F44-44DC-9E5E-0AD8B705DCD1 Q34163933-F6D91C57-97AD-4DF2-A256-3986775FE634 Q34247267-0B8CA824-EF2C-4B45-8DCB-B67B257C61E3 Q34362287-DC81F735-4CDA-43B4-8D46-AFFDADB807C7 Q34404086-FD3E143E-1E27-4038-9462-67F5DDEFADA4 Q34407627-71A1D4A5-DF9A-4580-BD34-B7F2BA431C28 Q34536235-8BBDB09B-C3A2-4AE5-8EC7-D87D9684FD0C Q34550041-E8760AD8-42CF-4AC0-81E5-29D56C94D619

P2860

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)

http://www.wikidata.org/entity/Q28211911

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@ast

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@en

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@nl

type

label

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@ast

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@en

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@nl

prefLabel

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@ast

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@en

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@nl

P1433

Q28211911-CE5D6AC9-D639-4779-82CB-822D58F64169

P1476

Q28211911-92C5E802-45D6-420D-A999-5382B879C9C0

P2093

Q28211911-1199CB81-6726-4AAB-B22F-729C28C5CB05

Q28211911-52DFDBD0-650D-46B6-BFAD-47F77BCD0673

Q28211911-740DF423-9061-44AB-8E1C-FE17F94DFE55

Q28211911-8856BF67-0865-4779-9C0D-57A12B871C80

Q28211911-ABB5BA12-5768-4A49-B105-2D3024425711

Q28211911-BE1BD948-DEFF-4EF6-9072-EF1912AE4DF6

Q28211911-F27DF007-52C1-4AEC-B6B8-CB5397E2C076

P304

Q28211911-3BE8EB0E-AAA1-4FDD-82AC-632B1FE986C8

P31

Q28211911-FD846A9C-E536-48E2-94D6-757B71D99492

P3181

Q28211911-2DA61EDD-A73A-4E91-9505-FD0EBD8ECFCE

P356

Q28211911-EC90AAA4-0AE3-486E-8BBD-67270D029403

P407

Q28211911-2FF88AC8-519A-43AC-88AC-06885742286E

P433

Q28211911-C7042AB4-7729-42ED-BFDF-84BA41CED9D6

P478

Q28211911-2D6886E4-E747-4769-8D61-10177B41976A

P577

Q28211911-7BA3AD83-6626-4865-8B25-9EDE9150E24F

P698

Q28211911-8F641462-2878-4361-BB43-5669D7FBDE49

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)

@en

P2093

C P Blobel

http://www.w3.org/2001/XMLSchema#string

D R Greaves

http://www.w3.org/2001/XMLSchema#string

E W Raines

http://www.w3.org/2001/XMLSchema#string

G Murphy

http://www.w3.org/2001/XMLSchema#string

K J Garton

http://www.w3.org/2001/XMLSchema#string

P J Dempsey

http://www.w3.org/2001/XMLSchema#string

P J Gough

http://www.w3.org/2001/XMLSchema#string

P304

37993-8001

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2581838

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M106434200

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

276

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11495925

http://www.w3.org/2001/XMLSchema#string